+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Drug Delivery Devices Global Market Report 2024

  • PDF Icon

    Report

  • 250 Pages
  • February 2024
  • Region: Global
  • The Business Research Company
  • ID: 5939645

Quick Summary:

As the landscape of healthcare evolves, the drug delivery devices market stands as a pivotal segment addressing the critical needs of modern medicine. The advent of innovative and technologically advanced drug delivery mechanisms is revolutionizing patient care and therapeutic efficacy across a spectrum of diseases.

Senior business executives seeking competitive intelligence in this dynamic sector will find this market research report indispensable. It unpacks the complexities of the market, providing an authoritative analysis of current trends, future developments, and strategic opportunities. This comprehensive report is tailored to inform top-level decision-making and investment strategies, offering a granular overview of the market's trajectory.

Given the surge in demand for more efficient and patient-friendly drug delivery options, businesses poised to invest in this market can leverage significant growth potential. Our in-depth report offers critical insights that will empower your enterprise to navigate the market with confidence, identify lucrative avenues for expansion, and stay ahead of the curve in innovation. Embrace this opportunity to inform your strategic planning with data-driven intelligence and expert analysis.

The drug delivery devices market size has grown strongly in recent years. It will grow from $87.65 billion in 2023 to $94.7 billion in 2024 at a compound annual growth rate (CAGR) of 8.0%. The expansion observed in the past can be credited to the swift increase in the elderly population, a rise in the number of healthcare facilities, economic growth in emerging markets, and an augmentation in healthcare expenditure.

The drug delivery devices market size is expected to see strong growth in the next few years. It will grow to $122.07 billion in 2028 at a compound annual growth rate (CAGR) of 6.6%. The anticipated expansion in the upcoming period can be ascribed to the rising prevalence of chronic diseases, growing demand for injectables, an increasing need for drug delivery devices, and the sudden emergence of severe infections. Key trends expected in the forecast period involve investments in microneedle drug technology for drug delivery, the research and development of self-injectable drug delivery devices, a focus on mergers and acquisitions, and investments in wearable drug delivery devices.

The increasing prevalence of chronic diseases such as cardiovascular diseases, diabetes, cancer, and other conditions is expected to propel the drug delivery devices market. For example, in January 2023, according to the National Library of Medicine, the number of individuals in the United States aged 50 and older with at least one chronic condition is projected to increase by 99.5%, reaching 142.66 million by 2050 from 71.522 million in 2020. Various routes of drug administration exist, and the choice depends on three factors, the desired effect, the type of disease, and the product type. The pharmaceutical industry is currently emphasizing the development of new drug delivery systems, driven by increasing R&D efforts worldwide due to the rising prevalence of chronic diseases. Many pharmaceutical companies are concentrating on multiple drug delivery technologies to enhance advantages and improve outcomes for their products. Therefore, the growing prevalence of chronic diseases is leading to increased consumption of therapeutic drugs and therapies, acting as a driver for the drug delivery devices market's growth.

The increasing demand for biologics is expected to contribute to the expansion of the drug delivery device market. Biologics, also known as biologic products or biopharmaceuticals, are pharmaceuticals developed using living organisms, cells, or biological processes. Drug delivery devices play a crucial role in enhancing biologics delivery by improving delivery methods, providing non-invasive delivery, protecting cargo, offering controlled release, enabling targeted delivery, and providing advanced drug delivery systems. In June 2023, according to the Government of Canada, Canada ranked among the top nations in the Organization for Economic Co-operation and Development (OECD) in terms of per capita spending in 2021, with biologics sales exceeding $11 billion. Hence, the increasing demand for biologics is a driving force for the growth of the drug delivery device market.

Leading companies in the drug delivery device market are strategically focusing on the development of innovative devices, such as autoinjectors with fully integrated connectivity, to gain a competitive advantage. Autoinjectors are specialized medical devices designed for self-administration of pre-measured medication doses. For example, in December 2021, Ypsomed AG, a Switzerland-based manufacturer of injection and infusion equipment, introduced YpsoMate, an autoinjector featuring fully integrated connectivity. The device is equipped with standard built-in Bluetooth communication, enabling connectivity to mobile phones and tablets for the transfer of injection and device data. This autoinjector provides digital therapy support by automatically recording medication administrations and sharing data with healthcare providers.

Microneedle (MN) technology is recognized for its efficiency and versatility in the medical device landscape, boasting attributes such as painless penetration, cost-effectiveness, high therapeutic efficacy, and relative safety. Key players in the global microneedle drug delivery system market include 3M, Vetter Pharma International GmbH, Nano Biosciences LLC, Nano Pass, and others. Microneedles are crafted using biodegradable polymers that encapsulate drugs or vaccines. Upon dissolution in the skin, the microneedles release the drug. This innovative delivery method facilitates the passage of a diverse range of molecules through the skin barrier, allowing transdermal delivery for various clinical applications, including diabetes, severe osteoporosis, and influenza vaccination.

In March 2022, Sandoz Group AG, a Switzerland-based pharmaceutical company, acquired Coalesce Product Development Limited for an undisclosed amount. This acquisition aligns with Sandoz's strategic goal of expanding its current respiratory medication portfolio and enhancing patient access to advanced treatments. Coalesce Product Development Limited, based in the UK, specializes in the manufacturing of respiratory medical and medication delivery devices.

Major companies operating in the drug delivery devices market report are Becton, Dickinson and Company, Baxter International, B. Braun Melsungen AG, Catalent, 3M Company, West Pharmaceutical Services, Inc., Gerresheimer AG, Smiths Medical, Boehringer Ingelheim, SMC Ltd., Elcam Medical, Eli Lilly and Company, Gerresheimer, Injex, Novartis AG, Novo Nordisk A/S, Pfizer Inc., Sanofi Sa, Schott AG, Terumo Corporation, Teva Pharmaceuticals, West Pharmaceuticals, Ypsomed Holding AG, F. Hoffmann-La Roche AG, GlaxoSmithKline, AstraZeneca, Congenica Ltd., UCB, Alkermes, Aptalis Pharma, Inc., Johnson & Johnson, Nektar Therapeutics, SkyePharma PLC, Pharmasyntez, NEARMEDIC PLUS LLC, Copernicus, Medtronic, Philips, Siemens, Stryker, GE Healthcare, Teleflex Medical, Gilero, Kedalion Therapeutics, MediPrint Ophthalmics, Nemera, Pendant Biosciences, Battelle Medical Devices, Merck & Co. Inc., Antares Pharma, Abbot, Allergan, Bilim Pharmaceuticals, H&T Presspart, Hovione Technology, Sorrel Medical, Syqe Medical, Julphar, ResMed Inc., Covidien plc


North America was the largest region in the drug delivery devices market in 2023. Asia-Pacific was the second-largest region in the global drug delivery devices market. The regions covered in the drug delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the drug delivery devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain.

The primary routes of drug administration through these devices encompass oral drug delivery, injectable drug delivery, topical drug delivery, ocular drug delivery, pulmonary drug delivery, nasal drug delivery, transmucosal drug delivery, and implantable drug delivery. Oral drug delivery involves the administration of a tablet or capsule into the alimentary canal of a human being. Patient care settings where these devices are utilized include hospitals, diagnostic centers, ambulatory surgery centers/clinics, home care settings, and others. The diverse applications of these drug delivery devices span across areas such as cancer, infectious diseases, respiratory diseases, diabetes, cardiovascular diseases, autoimmune diseases, central nervous system disorders, and more.

The drug delivery devices market research report is one of a series of new reports that provides drug delivery devices market statistics, including drug delivery devices industry global market size, regional shares, competitors with a drug delivery devices market share, detailed drug delivery devices market segments, market trends and opportunities, and any further data you may need to thrive in the drug delivery devices industry. This drug delivery devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The drug delivery devices market consists of sales of instruments such as smart pills, inhalers and nebulizers, drug-eluting stents, safety syringes, and transdermal patches. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary2. Drug Delivery Devices Market Characteristics3. Drug Delivery Devices Market Trends and Strategies
4. Drug Delivery Devices Market - Macro Economic Scenario
4.1. Impact of High Inflation on the Market
4.2. Ukraine-Russia War Impact on the Market
4.3. COVID-19 Impact on the Market
5. Global Drug Delivery Devices Market Size and Growth
5.1. Global Drug Delivery Devices Market Drivers and Restraints
5.1.1. Drivers of the Market
5.1.2. Restraints of the Market
5.2. Global Drug Delivery Devices Historic Market Size and Growth, 2018-2023, Value ($ Billion)
5.3. Global Drug Delivery Devices Forecast Market Size and Growth, 2023-2028, 2033F, Value ($ Billion)
6. Drug Delivery Devices Market Segmentation
6.1. Global Drug Delivery Devices Market, Segmentation by Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Oral Drug Delivery
  • Injectable Drug Delivery
  • Topical Drug Delivery
  • Ocular Drug Delivery
  • Pulmonary Drug Delivery
  • Nasal Drug Delivery
  • Transmucosal Drug Delivery
  • Implantable Drug Delivery
6.2. Global Drug Delivery Devices Market, Segmentation by Patient Care Setting, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Diagnostic Centers
  • Ambulatory Surgery Centers/Clinics
  • Home Care Settings
  • Other Patient Care Settings
6.3. Global Drug Delivery Devices Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Cancer
  • Infectious Diseases
  • Respiratory Diseases
  • Diabetes
  • Cardiovascular Diseases
  • Autoimmune Diseases
  • Central Nervous System Disorders
  • Other Applications
7. Drug Delivery Devices Market Regional and Country Analysis
7.1. Global Drug Delivery Devices Market, Split by Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Drug Delivery Devices Market, Split by Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8. Asia-Pacific Drug Delivery Devices Market
8.1. Asia-Pacific Drug Delivery Devices Market Overview
Region Information, Impact of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Drug Delivery Devices Market, Segmentation by Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Drug Delivery Devices Market, Segmentation by Patient Care Setting, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Drug Delivery Devices Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
9. China Drug Delivery Devices Market
9.1. China Drug Delivery Devices Market Overview
9.2. China Drug Delivery Devices Market, Segmentation by Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Drug Delivery Devices Market, Segmentation by Patient Care Setting, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Drug Delivery Devices Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
10. India Drug Delivery Devices Market
10.1. India Drug Delivery Devices Market, Segmentation by Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Drug Delivery Devices Market, Segmentation by Patient Care Setting, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Drug Delivery Devices Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11. Japan Drug Delivery Devices Market
11.1. Japan Drug Delivery Devices Market Overview
11.2. Japan Drug Delivery Devices Market, Segmentation by Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Drug Delivery Devices Market, Segmentation by Patient Care Setting, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Drug Delivery Devices Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12. Australia Drug Delivery Devices Market
12.1. Australia Drug Delivery Devices Market, Segmentation by Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Drug Delivery Devices Market, Segmentation by Patient Care Setting, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Drug Delivery Devices Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13. Indonesia Drug Delivery Devices Market
13.1. Indonesia Drug Delivery Devices Market, Segmentation by Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Drug Delivery Devices Market, Segmentation by Patient Care Setting, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Drug Delivery Devices Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14. South Korea Drug Delivery Devices Market
14.1. South Korea Drug Delivery Devices Market Overview
14.2. South Korea Drug Delivery Devices Market, Segmentation by Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Drug Delivery Devices Market, Segmentation by Patient Care Setting, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Drug Delivery Devices Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15. Western Europe Drug Delivery Devices Market
15.1. Western Europe Drug Delivery Devices Market Overview
15.2. Western Europe Drug Delivery Devices Market, Segmentation by Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Drug Delivery Devices Market, Segmentation by Patient Care Setting, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Drug Delivery Devices Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16. UK Drug Delivery Devices Market
16.1. UK Drug Delivery Devices Market, Segmentation by Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Drug Delivery Devices Market, Segmentation by Patient Care Setting, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Drug Delivery Devices Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17. Germany Drug Delivery Devices Market
17.1. Germany Drug Delivery Devices Market, Segmentation by Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Drug Delivery Devices Market, Segmentation by Patient Care Setting, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Drug Delivery Devices Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18. France Drug Delivery Devices Market
18.1. France Drug Delivery Devices Market, Segmentation by Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Drug Delivery Devices Market, Segmentation by Patient Care Setting, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Drug Delivery Devices Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19. Italy Drug Delivery Devices Market
19.1. Italy Drug Delivery Devices Market, Segmentation by Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Drug Delivery Devices Market, Segmentation by Patient Care Setting, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Drug Delivery Devices Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20. Spain Drug Delivery Devices Market
20.1. Spain Drug Delivery Devices Market, Segmentation by Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Drug Delivery Devices Market, Segmentation by Patient Care Setting, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Drug Delivery Devices Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21. Eastern Europe Drug Delivery Devices Market
21.1. Eastern Europe Drug Delivery Devices Market Overview
21.2. Eastern Europe Drug Delivery Devices Market, Segmentation by Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Drug Delivery Devices Market, Segmentation by Patient Care Setting, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Drug Delivery Devices Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22. Russia Drug Delivery Devices Market
22.1. Russia Drug Delivery Devices Market, Segmentation by Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Drug Delivery Devices Market, Segmentation by Patient Care Setting, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Drug Delivery Devices Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23. North America Drug Delivery Devices Market
23.1. North America Drug Delivery Devices Market Overview
23.2. North America Drug Delivery Devices Market, Segmentation by Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Drug Delivery Devices Market, Segmentation by Patient Care Setting, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Drug Delivery Devices Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24. USA Drug Delivery Devices Market
24.1. USA Drug Delivery Devices Market Overview
24.2. USA Drug Delivery Devices Market, Segmentation by Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Drug Delivery Devices Market, Segmentation by Patient Care Setting, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Drug Delivery Devices Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25. Canada Drug Delivery Devices Market
25.1. Canada Drug Delivery Devices Market Overview
25.2. Canada Drug Delivery Devices Market, Segmentation by Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Drug Delivery Devices Market, Segmentation by Patient Care Setting, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Drug Delivery Devices Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26. South America Drug Delivery Devices Market
26.1. South America Drug Delivery Devices Market Overview
26.2. South America Drug Delivery Devices Market, Segmentation by Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Drug Delivery Devices Market, Segmentation by Patient Care Setting, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Drug Delivery Devices Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27. Brazil Drug Delivery Devices Market
27.1. Brazil Drug Delivery Devices Market, Segmentation by Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Drug Delivery Devices Market, Segmentation by Patient Care Setting, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Drug Delivery Devices Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28. Middle East Drug Delivery Devices Market
28.1. Middle East Drug Delivery Devices Market Overview
28.2. Middle East Drug Delivery Devices Market, Segmentation by Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Drug Delivery Devices Market, Segmentation by Patient Care Setting, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Drug Delivery Devices Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29. Africa Drug Delivery Devices Market
29.1. Africa Drug Delivery Devices Market Overview
29.2. Africa Drug Delivery Devices Market, Segmentation by Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Drug Delivery Devices Market, Segmentation by Patient Care Setting, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Drug Delivery Devices Market, Segmentation by Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
30. Drug Delivery Devices Market Competitive Landscape and Company Profiles
30.1. Drug Delivery Devices Market Competitive Landscape
30.2. Drug Delivery Devices Market Company Profiles
30.2.1. Becton, Dickinson and Company
30.2.1.1. Overview
30.2.1.2. Products and Services
30.2.1.3. Strategy
30.2.1.4. Financial Performance
30.2.2. Baxter International
30.2.2.1. Overview
30.2.2.2. Products and Services
30.2.2.3. Strategy
30.2.2.4. Financial Performance
30.2.3. B. Braun Melsungen AG
30.2.3.1. Overview
30.2.3.2. Products and Services
30.2.3.3. Strategy
30.2.3.4. Financial Performance
30.2.4. Catalent
30.2.4.1. Overview
30.2.4.2. Products and Services
30.2.4.3. Strategy
30.2.4.4. Financial Performance
30.2.5. 3M Company
30.2.5.1. Overview
30.2.5.2. Products and Services
30.2.5.3. Strategy
30.2.5.4. Financial Performance
31. Drug Delivery Devices Market Other Major and Innovative Companies
31.1. West Pharmaceutical Services, Inc.
31.2. Gerresheimer AG
31.3. Smiths Medical
31.4. Boehringer Ingelheim
31.5. SMC Ltd.
31.6. Elcam Medical
31.7. Eli Lilly and Company
31.8. Gerresheimer
31.9. Injex
31.10. Novartis AG
31.11. Novo Nordisk A/S
31.12. Pfizer Inc
31.13. Sanofi Sa
31.14. Schott AG
31.15. Terumo Corporation
32. Global Drug Delivery Devices Market Competitive Benchmarking33. Global Drug Delivery Devices Market Competitive Dashboard34. Key Mergers and Acquisitions in the Drug Delivery Devices Market
35. Drug Delivery Devices Market Future Outlook and Potential Analysis
35.1 Drug Delivery Devices Market in 2028 - Countries Offering Most New Opportunities
35.2 Drug Delivery Devices Market in 2028 - Segments Offering Most New Opportunities
35.3 Drug Delivery Devices Market in 2028 - Growth Strategies
35.3.1 Market Trend-based Strategies
35.3.2 Competitor Strategies
36. Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic and Forecast Inflation Rates
36.4. Research Inquiries
36.5. About the Analyst
36.6. Copyright and Disclaimer

Executive Summary

Drug Delivery Devices Global Market Report 2024 provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on drug delivery devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia-Ukraine war’s impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis.
  • Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for drug delivery devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? This report answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:
  • The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.
  • The impact of higher inflation in many countries and the resulting spike in interest rates.
  • The continued but declining impact of COVID-19 on supply chains and consumption patterns.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Report Scope

Markets Covered:
1) By Product: Tapered Implants; Parallel Walled Implants
2) By Material: Titanium; Zirconium; Other Materials
3) By End-Use: Hospitals; Dental Clinics; Other End Uses

Key Companies Mentioned: Becton, Dickinson and Company; Baxter International; B. Braun Melsungen AG; Catalent; 3M Company

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time Series: Five years historic and ten years forecast

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita

Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes

Delivery Format: PDF, Word and Excel Data Dashboard

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Becton, Dickinson and Company
  • Baxter International
  • B. Braun Melsungen AG
  • Catalent
  • 3M Company
  • West Pharmaceutical Services, Inc.
  • Gerresheimer AG
  • Smiths Medical
  • Boehringer Ingelheim
  • SMC Ltd.
  • Elcam Medical
  • Eli Lilly and Company
  • Gerresheimer
  • Injex
  • Novartis AG
  • Novo Nordisk A/S
  • Pfizer Inc
  • Sanofi Sa
  • Schott AG
  • Terumo Corporation
  • Teva Pharmaceuticals
  • West Pharmaceuticals
  • Ypsomed Holding AG
  • F. Hoffmann-La Roche AG
  • GlaxoSmithKline
  • AstraZeneca
  • Congenica Ltd.
  • UCB
  • Alkermes
  • Aptalis Pharma, Inc.
  • Johnson & Johnson
  • Nektar Therapeutics
  • SkyePharma PLC
  • Pharmasyntez
  • NEARMEDIC PLUS LLC
  • Copernicus
  • Medtronic
  • Philips
  • Siemens
  • Stryker
  • GE Healthcare
  • Teleflex Medical
  • Gilero
  • Kedalion Therapeutics
  • MediPrint Ophthalmics
  • Nemera
  • Pendant Biosciences
  • Battelle Medical Devices
  • Merck & Co. Inc.
  • Antares Pharma
  • Abbot
  • Allergan
  • Bilim Pharmaceuticals
  • H&T Presspart
  • Hovione Technology
  • Sorrel Medical
  • Syqe Medical
  • Julphar
  • ResMed Inc
  • Covidien plc

Methodology

Loading
LOADING...